Development of a Commercial Manufacturing Process for Sotorasib, a First-in-Class KRASG12C Inhibitor

Описание к видео Development of a Commercial Manufacturing Process for Sotorasib, a First-in-Class KRASG12C Inhibitor

Andrew Parsons presents the development of a commercial manufacturing process for sotorasib, a first-in-class KRASG12C inhibitor.

Sponsored by Porton Pharma.
02:48 Introduction
03:21 Speaker Q&A
08:08 Presentation
43:27 Q&A

Presented on Apr. 19, 2023 as part of the Drug Hunter Flash Talk series.

Sign up for future sessions here: https://lu.ma/w1q906iz

Комментарии

Информация по комментариям в разработке

Похожие видео